Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name	NCATS Issued	FOA Number	Activity Code	Posting Date	Expiration Date	Opportunity Type
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NCATS Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Funding Opportunity Announcement	✔	NOT-TR-19-004		10/15/2018		NA
Notice of NCATS Participation in RFA-HL-19-018 NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 - Clinical Trial Optional)	✔	NOT-TR-18-026		05/16/2018		NA
Notice of Corrected Expiration Date for PA-15-354 "SBIR Technology Transfer (R43/R44)"	✘	NOT-NS-18-031		01/11/2018		NA
Notice of Clarification for PA-15-354 "SBIR Technology Transfer (R43/R44)"	✘	NOT-NS-16-007		02/11/2016		NA
Notice Clarifying SBIR Direct-to-Phase II Eligibility Criteria	✘	NOT-OD-16-052		01/12/2016		Policy Notice
Notice of Participation of NCATS in RFA-HL-14-012 Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44)	✔	NOT-TR-13-006		04/15/2013		NA
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health	✘	NOT-EB-23-005	U44, R43/R44, R41/R42	07/26/2023	09/08/2025	Notice of Special Interest
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)	✔	PAR-23-267	U43/U44	04/18/2023	10/06/2025	NA

Last updated on February 19, 2025